OMEROS CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
OMEROS CORP (OMER) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 833.14 thousand shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2022-03-01
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2021-03-31 was 69.60K shares, a 28.14% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2020-12-31 was 315.08K shares, a 119.93% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2020-09-30 was 493.27K shares, a 294.74% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2020-06-30 was 87.84K shares, a 30.14% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2021 was 833.14K shares, a 12.35% decline from fiscal 2020.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2020 was 950.52K shares, a 135.22% increase from fiscal 2019.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2019 was 404.10K shares, a 14.01% decline from fiscal 2018.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2018 was 469.93K shares, a 19.69% decline from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2021-12-31 | 833.14K shares 10-K · filed 2022-03-01 | |||
| 2021-03-31 | 69.60K shares 10-Q · filed 2021-05-10 | 384.69K shares derived: sum of 2 quarters · filed 2021-05-10 | 877.96K shares derived: sum of 3 quarters · filed 2021-05-10 | 965.80K shares derived: sum of 4 quarters · filed 2021-05-10 |
| 2020-12-31 | 315.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 808.36K shares derived: sum of 2 quarters · filed 2021-03-01 | 896.20K shares derived: sum of 3 quarters · filed 2021-03-01 | 950.52K shares 10-K · filed 2021-03-01 |
| 2020-09-30 | 493.27K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 581.12K shares derived: sum of 2 quarters · filed 2020-11-09 | 635.43K shares 10-Q · filed 2020-11-09 | 778.70K shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | 87.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 142.16K shares 10-Q · filed 2020-08-10 | 285.42K shares derived: sum of 3 quarters · filed 2020-08-10 | 410.39K shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | 54.32K shares 10-Q · filed 2020-05-11 | 197.58K shares derived: sum of 2 quarters · filed 2020-05-11 | 322.55K shares derived: sum of 3 quarters · filed 2020-05-11 | 390.04K shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | 143.27K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 268.23K shares derived: sum of 2 quarters · filed 2020-03-02 | 335.72K shares derived: sum of 3 quarters · filed 2020-03-02 | 404.10K shares 10-K · filed 2020-03-02 |
| 2019-09-30 | 124.96K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 192.46K shares derived: sum of 2 quarters · filed 2019-11-12 | 260.83K shares 10-Q · filed 2019-11-12 | 268.40K shares derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | 67.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 135.87K shares 10-Q · filed 2019-08-08 | 143.44K shares derived: sum of 3 quarters · filed 2019-08-08 | 202.63K shares derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | 68.37K shares 10-Q · filed 2019-05-09 | 75.94K shares derived: sum of 2 quarters · filed 2019-05-09 | 135.13K shares derived: sum of 3 quarters · filed 2019-05-09 | 516.56K shares derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-12-31 | 7.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | 66.76K shares derived: sum of 2 quarters · filed 2019-03-01 | 448.19K shares derived: sum of 3 quarters · filed 2019-03-01 | 469.93K shares 10-K · filed 2019-03-01 |
| 2018-09-30 | 59.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 440.62K shares derived: sum of 2 quarters · filed 2018-11-08 | 462.36K shares 10-Q · filed 2018-11-08 | 484.03K shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 381.43K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 403.17K shares 10-Q · filed 2018-08-09 | 424.84K shares derived: sum of 3 quarters · filed 2018-08-09 | 473.97K shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 21.74K shares 10-Q · filed 2018-05-10 | 43.41K shares derived: sum of 2 quarters · filed 2018-05-10 | 92.54K shares derived: sum of 3 quarters · filed 2018-05-10 | 364.19K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 21.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 70.80K shares derived: sum of 2 quarters · filed 2018-03-01 | 342.45K shares derived: sum of 3 quarters · filed 2018-03-01 | 585.16K shares 10-K · filed 2018-03-01 |
| 2017-09-30 | 49.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 320.78K shares derived: sum of 2 quarters · filed 2017-11-09 | 563.49K shares 10-Q · filed 2017-11-09 | 616.57K shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 271.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 514.36K shares 10-Q · filed 2017-08-08 | 567.44K shares derived: sum of 3 quarters · filed 2017-08-08 | 608.58K shares derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | 242.71K shares 10-Q · filed 2017-05-10 | 295.79K shares derived: sum of 2 quarters · filed 2017-05-10 | 336.93K shares derived: sum of 3 quarters · filed 2017-05-10 | 358.05K shares derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | 53.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 94.21K shares derived: sum of 2 quarters · filed 2017-03-16 | 115.33K shares derived: sum of 3 quarters · filed 2017-03-16 | 143.26K shares 10-K · filed 2017-03-16 |
| 2016-09-30 | 41.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 62.26K shares derived: sum of 2 quarters · filed 2016-11-09 | 90.19K shares 10-Q · filed 2016-11-09 | 150.56K shares derived: sum of 4 quarters · filed 2016-11-09 |
| 2016-06-30 | 21.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 49.05K shares 10-Q · filed 2016-08-09 | 109.42K shares derived: sum of 3 quarters · filed 2016-08-09 | 134.00K shares derived: sum of 4 quarters · filed 2016-08-09 |
| 2016-03-31 | 27.93K shares 10-Q · filed 2016-05-10 | 88.30K shares derived: sum of 2 quarters · filed 2016-05-10 | 112.89K shares derived: sum of 3 quarters · filed 2016-05-10 | 141.73K shares derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-12-31 | 60.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | 84.96K shares derived: sum of 2 quarters · filed 2016-03-15 | 113.80K shares derived: sum of 3 quarters · filed 2016-03-15 | 127.85K shares 10-K · filed 2016-03-15 |
| 2015-09-30 | 24.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 53.44K shares derived: sum of 2 quarters · filed 2015-11-09 | 67.48K shares 10-Q · filed 2015-11-09 | 166.64K shares derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | 28.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | 42.90K shares 10-Q · filed 2015-08-10 | 142.05K shares derived: sum of 3 quarters · filed 2015-08-10 | 170.11K shares derived: sum of 4 quarters · filed 2015-08-10 |
| 2015-03-31 | 14.05K shares 10-Q · filed 2015-05-11 | 113.21K shares derived: sum of 2 quarters · filed 2015-05-11 | 141.26K shares derived: sum of 3 quarters · filed 2015-05-11 | 163.16K shares derived: sum of 4 quarters · filed 2015-05-11 |
| 2014-12-31 | 99.16K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 127.22K shares derived: sum of 2 quarters · filed 2015-03-16 | 149.11K shares derived: sum of 3 quarters · filed 2015-03-16 | 313.38K shares 10-K · filed 2015-03-16 |
| 2014-09-30 | 28.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | 49.95K shares derived: sum of 2 quarters · filed 2014-11-10 | 214.22K shares 10-Q · filed 2014-11-10 | 227.27K shares derived: sum of 4 quarters · filed 2014-11-10 |
| 2014-06-30 | 21.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | 186.17K shares 10-Q · filed 2014-08-11 | 199.22K shares derived: sum of 3 quarters · filed 2014-08-11 | 290.99K shares derived: sum of 4 quarters · filed 2014-08-11 |
| 2014-03-31 | 164.27K shares 10-Q · filed 2014-05-12 | 177.32K shares derived: sum of 2 quarters · filed 2014-05-12 | 269.09K shares derived: sum of 3 quarters · filed 2014-05-12 | 321.95K shares derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | 13.05K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | 104.82K shares derived: sum of 2 quarters · filed 2014-03-13 | 157.68K shares derived: sum of 3 quarters · filed 2014-03-13 | 179.26K shares 10-K · filed 2014-03-13 |
| 2013-09-30 | 91.77K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | 144.63K shares derived: sum of 2 quarters · filed 2013-11-07 | 166.21K shares 10-Q · filed 2013-11-07 | 183.73K shares derived: sum of 4 quarters · filed 2013-11-07 |
| 2013-06-30 | 52.86K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | 74.44K shares 10-Q · filed 2013-08-09 | 91.96K shares derived: sum of 3 quarters · filed 2013-08-09 | 97.33K shares derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | 21.58K shares 10-Q · filed 2013-05-09 | 39.10K shares derived: sum of 2 quarters · filed 2013-05-09 | 44.47K shares derived: sum of 3 quarters · filed 2013-05-09 | |
| 2012-12-31 | 17.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | 22.89K shares derived: sum of 2 quarters · filed 2013-03-18 | 75.69K shares 10-K · filed 2013-03-18 | |
| 2012-09-30 | 5.37K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | 58.17K shares 10-Q · filed 2012-11-09 | ||
| 2012-06-30 | 52.80K shares 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |